Diagnosis and therapy of sepsis. Guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine

Der Internist
K ReinhartDeutschen Sepsis-Gesellschaft e.V. (DSG)

Abstract

A recent survey conducted by the publicly funded Competence Network Sepsis (SepNet) reveals that severe sepsis and/or septic shock occurs in 75,000 inhabitants (110 out of 100,000) and sepsis in 79,000 inhabitants (116 out of 100,000) in Germany annually. This illness is responsible for approximately 60,000 deaths and ranges as the third most frequent cause of death after acute myocardial infarction. Direct costs for the intensive care of patients with severe sepsis alone amount to approximately 1.77 billion euros, which means that about 30% of the budget in intensive care is used to treat severe sepsis. However, until now German guidelines for the diagnosis and therapy of severe sepsis did not exist. Therefore, the German Sepsis Society initiated the development of guidelines which are based on international recommendations by the International Sepsis Forum (ISF) and the Surviving Sepsis Campaign (SSC) and take into account the structure and organization of the German health care system. Priority was given to the following guideline topics: a) diagnosis, b) prevention, c) causative therapy, d) supportive therapy, e) adjunctive therapy. The guidelines development process was carefully planned and strictly adhered to the require...Continue Reading

Associated Clinical Trials

References

Apr 1, 1977·Annals of Internal Medicine·L S YoungE T Anderson
Feb 1, 1992·Critical Care Medicine·B A VanderheydenT Emanuele
Oct 8, 1992·The New England Journal of Medicine·D K CobbB M Farr
Sep 1, 1991·Archives of Internal Medicine·L LeiboviciA J Wysenbeek
Sep 16, 1991·The American Journal of Medicine·A JosephsonJ Blight
Dec 1, 1991·Critical Care Medicine·M A FoxH K van Saene
Dec 1, 1991·Critical Care Medicine·A RossiterP Carvajal
Dec 1, 1990·Postgraduate Medical Journal·E ShaharL Shenkman
May 1, 1990·The Journal of Antimicrobial Chemotherapy·R NauH W Prange
Jan 1, 1990·Intensive Care Medicine·J GodardJ Motin
Nov 1, 1990·Critical Care Medicine·J M Rodríguez-RoldánA J Martínez-Pellús
Oct 1, 1990·Annals of Internal Medicine·D W BatesT H Lee
May 1, 1968·Archives of Internal Medicine·M A Freid, K L Vosti
Jan 1, 1971·Archives of Internal Medicine·R E BryantM G Koenig

❮ Previous
Next ❯

Citations

Nov 24, 2007·Der Anaesthesist·B EllgerG Van den Berghe
Apr 23, 2009·Der Anaesthesist·G A GiesslerT Trupkovic
Dec 13, 2007·Critical Care Medicine·K Georg KreymannStefan Kluge
Oct 23, 2008·Critical Care : the Official Journal of the Critical Care Forum·Reiner M WaeschleMichael Quintel
Jun 2, 2009·Der Internist·F M Brunkhorst, K Reinhart
Aug 4, 2007·Der Anaesthesist·A E Goetz, K Heckel
May 27, 2010·Der Internist·H Ebelt, K Werdan
Apr 24, 2010·Der Urologe. Ausg. A·F M E WagenlehnerW Weidner
May 3, 2007·AACN Advanced Critical Care·Steven Q SimpsonAmy R O'Brien-Ladner
Jun 10, 2009·Der Internist·F M Brunkhorst, K Reinhart

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.